Literature DB >> 26193970

'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.

Zhi Fang1, Lin-Yan Wan1,2, Liang-Yin Chu3,4, Yan-Qiong Zhang1, Jiang-Feng Wu1,2.   

Abstract

INTRODUCTION: In the therapy of clinical diseases such as cancer, it is important to deliver drugs directly to tumor sites in order to maximize local drug concentration and reduce side effects. This objective may be realized by using 'smart' nanoparticles (NPs) as drug delivery systems, because they enable dramatic conformational changes in response to specific physical/chemical stimuli from the diseased cells for targeted and controlled drug release. AREAS COVERED: In this review, we first briefly summarize the characteristics of 'smart' NPs as drug delivery systems in medical therapy, and then discuss their targeting transport, transmembrane and endosomal escape behaviors. Lastly, we focus on the applications of 'smart' NPs as drug delivery systems for tumor therapy. EXPERT OPINION: Biodegradable 'smart' NPs have the potential to achieve maximum efficacy and drug availability at the desired sites, and reduce the harmful side effects for healthy tissues in tumor therapy. It is necessary to select appropriate NPs and modify their characteristics according to treatment strategies of tumor therapy.

Entities:  

Keywords:  controlled release; drug delivery; target delivery; tumor therapy; ‘smart’ nanoparticles

Mesh:

Substances:

Year:  2015        PMID: 26193970     DOI: 10.1517/17425247.2015.1071352

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  6 in total

1.  Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach.

Authors:  Steve McGaraughty; Rachel A Davis-Taber; Chang Z Zhu; Todd B Cole; Arthur L Nikkel; Meha Chhaya; Kelly J Doyle; Lauren M Olson; Gregory M Preston; Christine M Grinnell; Katherine M Salte; Anthony M Giamis; Yanping Luo; Victor Sun; Andrew D Goodearl; Murali Gopalakrishnan; Susan E Lacy
Journal:  J Am Soc Nephrol       Date:  2017-08-21       Impact factor: 10.121

Review 2.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

3.  In vitro DNA plasmid condensation and transfection through pH-responsive nanohydrogel.

Authors:  Fatemeh Farjadian; Abbas Behzad-Behbahani; Soliman Mohammadi-Samani; Soheila Ghasemi
Journal:  Prog Biomater       Date:  2022-05-09

Review 4.  The influencing factors and functions of DNA G-quadruplexes.

Authors:  Wen-Fang Yuan; Lin-Yan Wan; Hu Peng; Yuan-Mei Zhong; Wen-Li Cai; Yan-Qiong Zhang; Wen-Bing Ai; Jiang-Feng Wu
Journal:  Cell Biochem Funct       Date:  2020-02-13       Impact factor: 3.685

5.  Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.

Authors:  Jie Li; Shu Yao; Kai Wang; Zaijun Lu; Xuantao Su; Li Li; Cunzhong Yuan; Jinbo Feng; Shi Yan; Beihua Kong; Kun Song
Journal:  Cancer Sci       Date:  2018-05-07       Impact factor: 6.716

Review 6.  Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.

Authors:  Bonglee Kim; Ji-Eon Park; Eunji Im; Yongmin Cho; Jinjoo Lee; Hyo-Jung Lee; Deok-Yong Sim; Woon-Yi Park; Bum-Sang Shim; Sung-Hoon Kim
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.